文献速递瘢痕与激光

增生性瘢痕色素异常与POMC启动子甲基化无关

Promoter Methylation Status in Pro-opiomelanocortin Does Not Contribute to Dyspigmentation in Hypertrophic Scar.
PubMed 文献 · J Burn Care Res · 2020-01-01

该研究在Duroc猪增生性瘢痕模型中,检测色素沉着区与色素减退区瘢痕及正常皮肤活检组织的POMC基因表达和启动子甲基化状态。结果显示色素减退瘢痕中POMC表达较正常皮肤显著下调,启动子甲基化虽有显著变化,但不足以解释色素沉着或色素减退的发生。

要点

  • 色素减退瘢痕中POMC基因表达较正常皮肤显著下调
  • POMC启动子甲基化有显著改变,但不能解释色素异常
  • 后续应关注POMC转录调控的其他环节

核心结论

  • POMC启动子甲基化状态不足以解释增生性瘢痕色素沉着或色素减退的发生。

研究设计与样本

  • Duroc猪增生性瘢痕模型研究;比较色素沉着瘢痕、色素减退瘢痕与正常皮肤的活检组织。
  • DNA经亚硫酸氢盐转化后,用两套引物扩增POMC启动子附近两个不同CpG岛,扩增产物测序评估甲基化模式。

主要发现

  • 色素减退瘢痕中POMC基因表达较正常皮肤显著下调,与既往报道的蛋白表达水平一致。
  • POMC启动子甲基化存在显著变化,但无一能解释色素沉着或色素减退的发生。

临床怎么用

  • 瘢痕色素异常机制研究不宜局限于POMC启动子甲基化,应转向POMC转录调控的其他环节。

局限性

  • 研究采用Duroc猪增生性瘢痕模型,结论外推至人需谨慎。
  • 仅检测POMC启动子附近两个CpG岛的甲基化,未覆盖其他调控区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burn injuries frequently result in hypertrophic scars (HTSs), specifically when excision and grafting are delayed due to limited resources or patient complications. In patient populations with dark baseline pigmentation, one symptom of HTS that often occurs is dyspigmentation. The mechanism behind dyspigmentation has not been explored, and, as such, prevention and treatment strategies for this morbidity are lacking. The mechanism by which cells make pigment is controlled at the apex of the pathway by pro-opiomelanocortin (POMC), which is cleaved to its products alpha-melanocyte-stimulating hormone (α-MSH) and adrenocorticotropin hormone (ACTH). α-MSH and ACTH secreted by keratinocytes bind to melanocortin 1 receptor (MC1R), expressed on melanocytes, to initiate melanogenesis. POMC protein expression is upregulated in hyperpigmented scar compared to hypopigmented scar by an unknown mechanism in a Duroc pig model of HTS. POMC RNA levels, as well as the POMC gene promoter methylation status were investigated as a possible mechanism. DNA was isolated from biopsies obtained from distinct areas of hyper- or hypopigmented scar and normal skin. DNA was bisulfite-converted, and amplified using two sets of primers to observe methylation patterns in two different CpG islands near the POMC promoter. Amplicons were then sequenced and methylation patterns were evaluated. POMC gene expression was significantly downregulated in hypopigmented scar compared to normal skin, consistent with previously reported protein expression levels. There were significant changes in methylation of the POMC promoter; however, none that would account for the development of hyper- or hypopigmentation. Future work will focus on other areas of POMC transcriptional regulation.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Carney BC, Dougherty RD, Moffatt LT, et al. Promoter Methylation Status in Pro-opiomelanocortin Does Not Contribute to Dyspigmentation in Hypertrophic Scar. J Burn Care Res. 2020. PMID: 31541238. doi:10.1093/jbcr/irz168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。